Skip to content
The Future Explorerby Benjamin Talin
The Inversion of the Population PyramidIn the book · Ch. 7Megatrend

Healthspan gap

Longevity and the Healthspan Gap

Lifespan is how long you live; healthspan is how long you live in good health. Medicine has become very good at stopping death and much less good at stopping decline, so lifespan grows faster than healthspan. Worldwide, people now spend on average about nine and a half years alive but not well. Treatments that slow decline itself barely exist, partly because nobody has agreed how to test them or who pays for them.

Lifespan extends faster than healthspan, so the years added are disproportionately years of managed illness.

1.8/ 5

Gradient 1.8 / 5 - weighed down most by the weakest enabler.

The average of these enablers is 2.3. The ramp runs at 1.8.

Shared weakest link at 1: Brain-Computer Interfaces, Longevity & Healthspan Interventions. The ramp is held back by all of them at once, and deepening one alone lifts it only a little.

In the network

Its enablers on the left, least mature first and drawn largest; the megatrends it is coupled with on the right. A thicker line is a heavier weight; the arrow shows which way a coupling pushes.weakest linkamplifies

Also shaped by The Closing of the Planetary Envelope (3 shared enablers) · The Collapse of Shared Reality (1 shared enabler) · The Decoupling of Physical and Digital Life (2 shared enablers) · The Optimisation of Everything (3 shared enablers) · The Rebuild of the Physical Base (5 shared enablers) · The Redistribution of Power (1 shared enabler)

Enablers

EnablerFamilyWeightMaturityRole
Brain-Computer Interfacestechnologicalmoderate
1/5
shared weakest link (with 1 other)
Longevity & Healthspan Interventionstechnologicallarge
1/5
shared weakest link (with 1 other)
Assistive & Care Technologytechnologicalmoderate
2/5
-
Regenerative Medicinetechnologicallarge
2/5
-
Regulatory Claritystructuralmoderate
2/5
-
BioTech & Genomicstechnologicallarge
3/5
-
Gene Editingtechnologicallarge
3/5
-
Vaccine Platforms & Antimicrobialstechnologicalmoderate
3/5
-
Nanotechnologytechnologicalmoderate
4/5
-

The gradient behaves like a sticky rubber band: it is pulled hardest toward the weakest enabler. Marginal links are shown but do not pull. Everything above 1 is strength this ramp can use only in part until the weakest link moves.

What this pushes on, and what pushes on it

Bound by

Healthspan interventions and the incentives to develop them

Medicine is good at preventing death and poor at preventing decline. A drug that stops decline has no settled endpoint, trial design or payer.

Momentum. Medicine is good at preventing death and poor at preventing decline, and the incentives in drug development reinforce that asymmetry.

The four clocks

Four systems absorb this at four speeds. The distance between them is the adaptation gap.

Individuals

months

Behaviour change is fast to start and rarely sustained; the outcome resolves over decades.

Companies

years

Years - the pharmaceutical pipeline is long and currently pointed at disease rather than at decline.

Governments

decades

Decades. Pension and care liabilities are set by this gap and are being priced as though it will close.

The biosphere

not ours to set

Not directly coupled.

Impacts by domain

Social & demographic

Global life expectancy reached 71.4 years in 2021, but healthy life expectancy stopped at 61.9 - a gap of 9.5 years that people now spend alive but not well (WHO, World Health Statistics 2024, May 2024).

Environmental

A global survey of 258 rivers across 104 countries found at least one pharmaceutical compound at unsafe concentrations in 25.7% of the 1,052 sites tested - the daily pill regimen of an ageing population, showing up downstream (Wilkinson et al., PNAS, February 2022).

Economic

The UK spends £7,500 a year on healthcare for the average person aged 85 or older, five times the £1,500 it spends on someone in their 30s or 40s (Office for Budget Responsibility, Fiscal Risks and Sustainability Report, July 2022).

Geopolitical

Over 60% of the EU's off-patent drug ingredients come from factories in India and China, and that dependency produced formal shortages of cardiovascular and antimicrobial medicines across 26 member states in 2023 (European Medicines Agency, October 2023).

What would prove this wrong

Healthy life expectancy rising at least as fast as total life expectancy across several countries for a decade.

Talin, B. (2026). Longevity and the Healthspan Gap. The Future Explorer, dataset v0.4.0 (2026-11-16). https://explorer.talin.digital/m/longevity-and-the-healthspan-gap/